Unexpected Anaphylaxis After Completing a Desensitization Protocol to Oxaliplatin: Successful Adjuvant Use of Omalizumab
- Resource Type
- Authors
- Pilar Tornero; I Torrado; A Rodríguez-Fernández; Alicia Prieto-García; P Rojas; B Noguerado
- Source
- Journal of Investigational Allergology and Clinical Immunology. 29:53-55
- Subject
- Oncology
medicine.medical_specialty
Drug desensitization
medicine.medical_treatment
Immunology
Drug allergy
Antineoplastic Agents
Omalizumab
Adenocarcinoma
Adjuvants, Immunologic
Internal medicine
Anti-Allergic Agents
medicine
Humans
Immunology and Allergy
Anaphylaxis
Peritoneal Neoplasms
Desensitization (medicine)
business.industry
Liver Neoplasms
Middle Aged
medicine.disease
Oxaliplatin
Treatment Outcome
Desensitization, Immunologic
Colonic Neoplasms
Female
business
Adjuvant
medicine.drug
- Language
- ISSN
- 1018-9068